Larcher, Alessandro;Wallis, Christopher J D;Pavan, Nicola;Porpiglia, Francesco;Takagi, Toshio;Tanabe, Kazunari;Rha, Koon H;Raheem, Ali Abdel;Yang, Bo;Zang, Chao;Perdonà, Sisto;Quarto, Giuseppe;Maurer, Tobias;Amiel, Thomas;Schips, Luigi;Castellucci, Roberto;Crivellaro, Simone;Dobbs, Ryan;Baiamonte, Gianfranco;Celia, Antonio;De Concilio, Bernardino;Furlan, Maria;Lima, Estevão;Linares, Estefania;Micali, Salvatore;Amparore, Daniele;De Naeyer, Geert;Trombetta, Carlo;Hampton, Lance J;Tracey, Andrew;Bindayi, Ahmet;Antonelli, Alessandro;Derweesh, Ithaar;Mir, Carme;Montorsi, Francesco;Mottrie, Alexandre;Autorino, Riccardo;Capitanio, Umberto
Outcomes of minimally invasive partial nephrectomy among very elderly patients: report from the RESURGE collaborative international database.
Cent European J Urol
2020
73
3
273-279

Bokemeyer, C.;Amram, M-L.;Stoiber, F.;Gschwend, J.
Cabazitaxel treatment in patients with metastatic castration-resistant prostate cancer (mCRPC) in daily practice: Interim analysis of the non-interventional SCOPE study
Ann Oncol
2020
31 Suppl 4
S517-S517

Hussain, Maha H. A.;Powles, Thomas;Albers, Peter;Castellano, Daniel;Daneshmand, Siamak;Gschwend, Juergen;Nishiyama, Hiroyuki;Oudard, Stephane;Tayama, Darren;Davarpanah, Nicole N.;Degaonkar, Viraj;Shi, Yi;Mariathasan, Sanjeev;Grivas, Petros;Peter, H. O.;Rosenberg, Jonathan E.;Geynisman, Daniel M.;Hoffman-Censits, Jean H.;Peter Petrylak, Daniel;Bellmunt, Joaquim
IMvigor010: Primary analysis from a phase III randomized study of adjuvant atezolizumab (atezo) versus observation (obs) in high-risk muscle-invasive urothelial carcinoma (MIUC).
J Clin Oncol
2020
38 Suppl S
15

Hahn, Noah M.;Chang, Sam;Meng, Maxwell;Shore, Neal D.;Konety, Badrinath R.;Steinberg, Gary D.;Gschwend, Juergen;Nishiyama, Hiroyuki;Palou, Joan;Taylor, John A.;Lambert, Alexandre;Zhu, Li;Maeda, Toshiki;Raybold, Bradley;Fischer, Bruce S.;Jeyamohan, Chandrika;Zardavas, Dimitrios;Witjes, Fred
A phase II, randomized study of nivolumab (NIVO), NIVO plus linrodostat mesylate, or NIVO plus intravesical bacillus Calmette-Guerin (BCG) in BCG-unresponsive, high-risk, nonmuscle invasive bladder cancer (NMIBC): CheckMate 9UT.
J Clin Oncol
2020
38 Suppl S
15

Sokolakis, I;Schoenbauer, P.;Gschwend, J.;Lahme, S.;Hatzichristodoulou, G.
SURGICAL TREATMENT OF CONGENITAL PENILE CURVATURE USING A MODIFIED EXCISIONAL CORPOROPLASTY TECHNIQUE
J Sex Med
2020
17 Suppl 2
6
S183-S183

Sonpavde, Guru;Necchi, Andrea;Gupta, Shilpa;Steinberg, Gary D.;Gschwend, Juergen;Van der Heijden, Michiel Simon;Richiero, Audrey;Lambert, Alexandre;Raybold, Bradley;Gajavelli, Srikanth;Zardavas, Dimitrios;Galsky, Matt D.
A phase III randomized study of neoadjuvant chemotherapy (NAC) alone or in combination with nivolumab (NIVO) +/- linrodostat mesylate, followed by adjuvant postsurgical NIVO +/- linrodostat, in cisplatin-eligible muscle invasive bladder cancer (MIBC).
J Clin Oncol
2020
38 Suppl S
15

von Amsberg, Gunhild;Gschwend, Juergen Erich
mHSPC therapy with apalutamide/ADT Foreword
Oncology Research and Treatment
2020
43 Suppl 2
5-5

Bokemeyer, Carsten;Otremba, Burkhard;Cathomas, Richard;Stoiber, Franz;Gschwend, Juergen
Activity of Two Routine Cabazitaxel Treatment Sequences in Patients with Metastatic Castration- Resistant Prostate Cancer (mCRPC) - Interim Analysis of The Non-Interventional Scope Study
Oncology Research and Treatment
2020
43 Suppl 1
78-79

Meissner, Valentin H;Strüh, Jamila G H;Kron, Martina;Liesenfeld, Lea A;Kranz, Stephanie;Gschwend, Jürgen E;Herkommer, Kathleen
The role of fatal family history and mode of inheritance in prostate cancer for long-term outcomes following radical prostatectomy.
World J Urol
2020
38
12
3091-3099

Jefferies, Benedict;Tong, Zhichao;Nawroth, Roman
Bioluminescence Imaging in the Chick Chorioallantoic Membrane Assay.
Methods Mol Biol
2020
2081
211-217